Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cough
Published in: Cough 1/2007

Open Access 01-12-2007 | Research

Analysis and evaluation of environmental tobacco smoke exposure as a risk factor for chronic cough

Authors: Beatrix Groneberg-Kloft, Wojciech Feleszko, Quoc Thai Dinh, Anke van Mark, Elke Brinkmann, Dirk Pleimes, Axel Fischer

Published in: Cough | Issue 1/2007

Login to get access

Abstract

Exposure to environmental tobacco smoke (ETS) and active tobacco smoking has been shown to increase symptoms of bronchial asthma such as bronchoconstriction but effects on other respiratory symptoms remain poorly assessed. Current levels of exposure to tobacco smoke may also be responsible for the development of chronic cough in both children and adults. The present study analyses the effects of tobacco smoke exposure as potential causes of chronic cough. A panel of PubMed-based searches was performed relating the symptom of cough to various forms of tobacco smoke exposure. It was found that especially prenatal and postnatal exposures to ETS have an important influence on children's respiratory health including the symptom of cough. These effects may be prevented if children and pregnant women are protected from exposure to ETS. Whereas the total number of studies adressing the relationship between cough and ETS exposure is relatively small, the present study demonstrated that there is a critical amout of data pointing to a causative role of environmental ETS exposure for the respiratory symptom of cough. Since research efforts have only targeted this effect to a minor extent, future epidemiological and experimental studies are needed to further unravel the relation between ETS and cough.
Appendix
Available only for authorised users
Literature
1.
Bitton A, Neuman MD, Barnoya J, Glantz SA: The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest. Lancet. 2005, 365 (9458): 531-540.PubMed
2.
Chilmonczyk BA, Salmun LM, Megathlin KN, Neveux LM, Palomaki GE, Knight GJ, Pulkkinen AJ, Haddow JE: Association between exposure to environmental tobacco smoke and exacerbations of asthma in children. N Engl J Med. 1993, 328 (23): 1665-1669. 10.1056/NEJM199306103282303.CrossRefPubMed
3.
DiFranza JR, Aligne CA, Weitzman M: Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics. 2004, 113 (4 Suppl): 1007-1015.PubMed
4.
5.
Floreani AA, Rennard SI: The role of cigarette smoke in the pathogenesis of asthma and as a trigger for acute symptoms. Curr Opin Pulm Med. 1999, 5 (1): 38-46. 10.1097/00063198-199901000-00007.CrossRefPubMed
6.
7.
8.
9.
10.
Yelin E, Katz P, Balmes J, Trupin L, Earnest G, Eisner M, Blanc P: Work Life of Persons with Asthma, Rhinitis, and COPD: A Study Using a National, Population-Based Sample. J Occup Med Toxicol. 2005, 1 (1): 2-10.1186/1745-6673-1-2.CrossRef
11.
Groneberg DA, Fischer A: Occupational Medicine and Toxicology. J Occup Med Toxicol. 2005, 1 (1): 1-10.1186/1745-6673-1-1.CrossRef
12.
Groneberg DA, Nowak D, Wussow A, Fischer A: Chronic cough due to occupational factors. J Occup Med Toxicol. 2005, 1 (1): 3-10.1186/1745-6673-1-3.CrossRef
13.
Groneberg DA, Wagner U, Chung KF: Mucus and fatal asthma. Am J Med. 2004, 116 (1): 66-67. 10.1016/j.amjmed.2003.08.023.CrossRefPubMed
14.
Chung KF, Groneberg DA: Effects of cigarette smoke on pulmonary homeostasis. Am J Respir Cell Mol Biol. 2005, 32 (2): 167-10.1165/rcmb.F288.CrossRefPubMed
15.
Chung KF, Caramori G, Groneberg DA: Airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004, 351 (14): 1459-1461. 10.1056/NEJM200409303511420.CrossRefPubMed
16.
Groneberg DA, Eynott PR, Lim S, Oates T, Wu R, Carlstedt I, Roberts P, McCann B, Nicholson AG, Harrison BD, Chung KF: Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology. 2002, 40 (4): 367-373. 10.1046/j.1365-2559.2002.01378.x.CrossRefPubMed
17.
Groneberg DA, Eynott PR, Oates T, Lim S, Wu R, Carlstedt I, Nicholson AG, Chung KF: Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir Med. 2002, 96 (2): 81-86. 10.1053/rmed.2001.1221.CrossRefPubMed
18.
Springer J, Groneberg DA, Pregla R, Fischer A: Inflammatory cells as source of tachykinin-induced mucus secretion in chronic bronchitis. Regul Pept. 2005, 124 (1-3): 195-201. 10.1016/j.regpep.2004.07.017.CrossRefPubMed
19.
Groneberg DA, Peiser C, Dinh QT, Matthias J, Eynott PR, Heppt W, Carlstedt I, Witt C, Fischer A, Chung KF: Distribution of respiratory mucin proteins in human nasal mucosa. Laryngoscope. 2003, 113 (3): 520-524. 10.1097/00005537-200303000-00023.CrossRefPubMed
20.
Chung KF, Widdicombe J: Acute and chronic cough. Pulm Pharmacol Ther. 2004, 17 (6): 471-473. 10.1016/j.pupt.2004.09.026.CrossRefPubMed
21.
Carr MJ: Plasticity of vagal afferent fibres mediating cough. Pulm Pharmacol Ther. 2004, 17 (6): 447-451. 10.1016/j.pupt.2004.09.020.CrossRefPubMed
22.
Mazzone SB: Sensory regulation of the cough reflex. Pulm Pharmacol Ther. 2004, 17 (6): 361-368. 10.1016/j.pupt.2004.09.021.CrossRefPubMed
23.
Canning BJ, Mazzone SB, Meeker SN, Mori N, Reynolds SM, Undem BJ: Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guinea-pigs. J Physiol. 2004, 557 (Pt 2): 543-558. 10.1113/jphysiol.2003.057885.PubMedCentralCrossRefPubMed
24.
Widdicombe JG: Overview of neural pathways in allergy and asthma. Pulm Pharmacol Ther. 2003, 16 (1): 23-30. 10.1016/S1094-5539(02)00178-5.CrossRefPubMed
25.
Belvisi MG: Sensory nerves and airway inflammation: role of A delta and C-fibres. Pulm Pharmacol Ther. 2003, 16 (1): 1-7. 10.1016/S1094-5539(02)00180-3.CrossRefPubMed
26.
Trevisani M, Gazzieri D, Benvenuti F, Campi B, Dinh QT, Groneberg DA, Rigoni M, Emonds-Alt X, Creminon C, Fischer A, Geppetti P, Harrison S: Ethanol Causes Inflammation in the Airways by a Neurogenic and TRPV1-Dependent Mechanism. J Pharmacol Exp Ther. 2004
27.
Groneberg DA, Niimi A, Dinh QT, Cosio B, Hew M, Fischer A, Chung KF: Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med. 2004, 170 (12): 1276-1280. 10.1164/rccm.200402-174OC.CrossRefPubMed
28.
Addington WR, Stephens RE, Widdicombe JG, Rekab K: Effect of stroke location on the laryngeal cough reflex and pneumonia risk. Cough. 2005, 1: 4-10.1186/1745-9974-1-4.PubMedCentralCrossRefPubMed
29.
Barr RL, McCrystal DJ, Perry CF, Chang AB: A rare cause of specific cough in a child: the importance of following-up children with chronic cough. Cough. 2005, 1: 8-10.1186/1745-9974-1-8.PubMedCentralCrossRefPubMed
30.
Fujimura M, Hara J, Myou S: Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids. Cough. 2005, 1: 5-10.1186/1745-9974-1-5.PubMedCentralCrossRefPubMed
31.
Coyle MA, Keenan DB, Henderson LS, Watkins ML, Haumann BK, Mayleben DW, Wilson MG: Evaluation of an ambulatory system for the quantification of cough frequency in patients with chronic obstructive pulmonary disease. Cough. 2005, 1: 3-10.1186/1745-9974-1-3.PubMedCentralCrossRefPubMed
32.
Hara J, Fujimura M, Myou S, Oribe Y, Furusho S, Kita T, Katayama N, Abo M, Ohkura N, Herai Y, Hori A, Ishiura Y, Nobata K, Ogawa H, Yasui M, Kasahara K, Nakao S: Comparison of cough reflex sensitivity after an inhaled antigen challenge between actively and passively sensitized guinea pigs. Cough. 2005, 1: 6-10.1186/1745-9974-1-6.PubMedCentralCrossRefPubMed
33.
Ishiura Y, Fujimura M, Nobata K, Abo M, Oribe T, Myou S, Nakamura H: Phosphodiesterase 3 inhibition and cough in elderly asthmatics. Cough. 2005, 1: 11-10.1186/1745-9974-1-11.PubMedCentralCrossRefPubMed
34.
Smith JA, Ashurst HL, Jack S, Woodcock AA, Earis JE: The description of cough sounds by healthcare professionals. Cough. 2006, 2: 1-10.1186/1745-9974-2-1.PubMedCentralCrossRefPubMed
35.
Torrego A, Cimbollek S, Hew M, Chung KF: No effect of omeprazole on pH of exhaled breath condensate in cough associated with gastro-oesophageal reflux. Cough. 2005, 1: 10-10.1186/1745-9974-1-10.PubMedCentralCrossRefPubMed
36.
Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G: American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med. 2003, 167 (5): 787-797. 10.1164/rccm.167.5.787.CrossRefPubMed
37.
38.
39.
40.
41.
McGarvey LP: Cough . 6: Which investigations are most useful in the diagnosis of chronic cough?. Thorax. 2004, 59 (4): 342-346. 10.1136/thx.2004.021832.PubMedCentralCrossRefPubMed
42.
43.
44.
Ahmedzai SH: Cough in cancer patients. Pulm Pharmacol Ther. 2004, 17 (6): 415-423. 10.1016/j.pupt.2004.09.015.CrossRefPubMed
45.
Chung KF, Widdicombe JG: Cough as a symptom. Pulm Pharmacol Ther. 2004, 17 (6): 329-332. 10.1016/j.pupt.2004.09.019.CrossRefPubMed
46.
Chung KF, Chang AB: Therapy for cough: active agents. Pulm Pharmacol Ther. 2002, 15 (3): 335-338. 10.1006/pupt.2002.0342.CrossRefPubMed
47.
Dicpinigaitis PV: Potential new cough therapies. Pulm Pharmacol Ther. 2004, 17 (6): 459-462. 10.1016/j.pupt.2004.09.010.CrossRefPubMed
48.
Fong J, Sandhu G, Ellaway P, Davey N, Strutton P, Murphy K, Guz A: What do we know about how humans cough?. Pulm Pharmacol Ther. 2004, 17 (6): 431-434. 10.1016/j.pupt.2004.09.007.CrossRefPubMed
49.
Fontana GA, Lavorini F, Geri P, Zanasi A, Piumelli R: Cough in children with congenital central hypoventilation syndrome. Pulm Pharmacol Ther. 2004, 17 (6): 425-429. 10.1016/j.pupt.2004.09.018.CrossRefPubMed
50.
Harrison NK: Idiopathic pulmonary fibrosis: a nervous cough?. Pulm Pharmacol Ther. 2004, 17 (6): 347-350. 10.1016/j.pupt.2004.09.029.CrossRefPubMed
51.
Ing AJ: Cough and gastro-oesophageal reflux disease. Pulm Pharmacol Ther. 2004, 17 (6): 403-413. 10.1016/j.pupt.2004.09.023.CrossRefPubMed
52.
McGarvey LP, Ing AJ: Idiopathic cough, prevalence and underlying mechanisms. Pulm Pharmacol Ther. 2004, 17 (6): 435-439. 10.1016/j.pupt.2004.09.012.CrossRefPubMed
53.
McGarvey LP, Nishino T: Acute and chronic cough. Pulm Pharmacol Ther. 2004, 17: 351-354. 10.1016/j.pupt.2004.09.017.CrossRefPubMed
54.
Morice AH: Post-nasal drip syndrome--a symptom to be sniffed at?. Pulm Pharmacol Ther. 2004, 17 (6): 343-345. 10.1016/j.pupt.2004.09.005.CrossRefPubMed
55.
Niimi A, Chung KF: Airway inflammation and remodelling changes in patients with chronic cough: do they tell us about the cause of cough?. Pulm Pharmacol Ther. 2004, 17 (6): 441-446. 10.1016/j.pupt.2004.09.004.CrossRefPubMed
56.
Page C, Reynolds SM, Mackenzie AJ, Geppetti P: Mechanisms of acute cough. Pulm Pharmacol Ther. 2004, 17 (6): 389-391. 10.1016/j.pupt.2004.09.028.CrossRefPubMed
57.
Pavord ID: Cough and asthma. Pulm Pharmacol Ther. 2004, 17 (6): 399-402. 10.1016/j.pupt.2004.09.009.CrossRefPubMed
58.
Smith JA, Calverley PM: Cough in chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2004, 17 (6): 393-398. 10.1016/j.pupt.2004.09.006.CrossRefPubMed
59.
60.
Iribarren C, Friedman GD, Klatsky AL, Eisner MD: Exposure to environmental tobacco smoke: association with personal characteristics and self reported health conditions. J Epidemiol Community Health. 2001, 55 (10): 721-728. 10.1136/jech.55.10.721.PubMedCentralCrossRefPubMed
61.
Kritz H, Schmid P, Sinzinger H: Passive smoking and cardiovascular risk. Arch Intern Med. 1995, 155 (18): 1942-1948. 10.1001/archinte.155.18.1942.CrossRefPubMed
62.
Ciruzzi M, Pramparo P, Esteban O, Rozlosnik J, Tartaglione J, Abecasis B, Cesar J, De Rosa J, Paterno C, Schargrodsky H: Case-control study of passive smoking at home and risk of acute myocardial infarction. Argentine FRICAS Investigators. Factores de Riesgo Coronario en America del Sur. J Am Coll Cardiol. 1998, 31 (4): 797-803. 10.1016/S0735-1097(98)00017-5.CrossRefPubMed
63.
Cardenas VM, Thun MJ, Austin H, Lally CA, Clark WS, Greenberg RS, Heath CW: Environmental tobacco smoke and lung cancer mortality in the American Cancer Society's Cancer Prevention Study. II. Cancer Causes Control. 1997, 8 (1): 57-64. 10.1023/A:1018483121625.CrossRefPubMed
64.
Strachan DP, Cook DG: Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 1997, 52 (10): 905-914.PubMedCentralCrossRefPubMed
65.
Strachan DP, Cook DG: Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax. 1998, 53 (3): 204-212.PubMedCentralCrossRefPubMed
66.
Strachan DP, Cook DG: Health effects of passive smoking. 4. Parental smoking, middle ear disease and adenotonsillectomy in children. Thorax. 1998, 53 (1): 50-56.PubMedCentralCrossRefPubMed
67.
Cook DG, Strachan DP: Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax. 1997, 52 (12): 1081-1094.PubMedCentralCrossRefPubMed
68.
69.
Cook DG, Strachan DP: Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax. 1999, 54 (4): 357-366.PubMedCentralCrossRefPubMed
70.
Cook DG, Strachan DP, Carey IM: Health effects of passive smoking. 9. Parental smoking and spirometric indices in children. Thorax. 1998, 53 (10): 884-893.PubMedCentralCrossRefPubMed
71.
Cook DG, Strachan DP, Carey IM: Health effects of passive smoking. Thorax. 1999, 54 (5): 469-PubMed
72.
Koo LC, Ho JH, Rylander R: Life-history correlates of environmental tobacco smoke: a study on nonsmoking Hong Kong Chinese wives with smoking versus nonsmoking husbands. Soc Sci Med. 1988, 26 (7): 751-760. 10.1016/0277-9536(88)90066-4.CrossRefPubMed
73.
Zemp E, Elsasser S, Schindler C, Kunzli N, Perruchoud AP, Domenighetti G, Medici T, Ackermann-Liebrich U, Leuenberger P, Monn C, Bolognini G, Bongard JP, Brandli O, Karrer W, Keller R, Schoni MH, Tschopp JM, Villiger B, Zellweger JP: Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). The SAPALDIA Team. Am J Respir Crit Care Med. 1999, 159 (4 Pt 1): 1257-1266.CrossRefPubMed
74.
Feleszko W, Zawadzka-Krajewska A, Matysiak K, Lewandowska D, Peradzynska J, Dinh QT, Hamelmann E, Groneberg DA, Kulus M: Parental tobacco smoking is associated with augmented IL-13 secretion in children with allergic asthma. J Allergy Clin Immunol. 2006, 117 (1): 97-102. 10.1016/j.jaci.2005.09.008.CrossRefPubMed
75.
Dicpinigaitis PV: Cough reflex sensitivity in cigarette smokers. Chest. 2003, 123 (3): 685-688. 10.1378/chest.123.3.685.CrossRefPubMed
76.
Dicpinigaitis PV, Sitkauskiene B, Stravinskaite K, Appel DW, Negassa A, Sakalauskas R: Effect of smoking cessation on cough reflex sensitivity. Eur Respir J. 2006, 28 (4): 786-790. 10.1183/09031936.06.00007806.CrossRefPubMed
77.
Sitkauskiene B, Stravinskaite K, Sakalauskas R, Dicpinigaitis PV: Changes in cough reflex sensitivity after cessation and resumption of cigarette smoking. Pulm Pharmacol Ther. 2007, 20 (3): 240-243. 10.1016/j.pupt.2006.08.005.CrossRefPubMed
78.
Bergren DR: Chronic tobacco smoke exposure increases cough to capsaicin in awake guinea pigs. Respir Physiol. 2001, 126 (2): 127-140. 10.1016/S0034-5687(01)00193-1.CrossRefPubMed
79.
Venners SA, Wang B, Ni J, Jin Y, Yang J, Fang Z, Xu X: Indoor air pollution and respiratory health in urban and rural China. Int J Occup Environ Health. 2001, 7 (3): 173-181.CrossRefPubMed
80.
Braun-Fahrlander C, Vuille JC, Sennhauser FH, Neu U, Kunzle T, Grize L, Gassner M, Minder C, Schindler C, Varonier HS, Wuthrich B: Respiratory health and long-term exposure to air pollutants in Swiss schoolchildren. SCARPOL Team. Swiss Study on Childhood Allergy and Respiratory Symptoms with Respect to Air Pollution, Climate and Pollen. Am J Respir Crit Care Med. 1997, 155 (3): 1042-1049.CrossRefPubMed
81.
Chhabra SK, Chhabra P, Rajpal S, Gupta RK: Ambient air pollution and chronic respiratory morbidity in Delhi. Arch Environ Health. 2001, 56 (1): 58-64.CrossRefPubMed
Metadata
Title
Analysis and evaluation of environmental tobacco smoke exposure as a risk factor for chronic cough
Authors
Beatrix Groneberg-Kloft
Wojciech Feleszko
Quoc Thai Dinh
Anke van Mark
Elke Brinkmann
Dirk Pleimes
Axel Fischer
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Cough / Issue 1/2007
Electronic ISSN: 1745-9974
DOI
https://doi.org/10.1186/1745-9974-3-6

Other articles of this Issue 1/2007

Cough 1/2007 Go to the issue

Commentary

Defining the relationship between gastroesophageal reflux and cough: probabilities, possibilities and limitations

Short report

Prevalence and clinical manifestations of gastro-oesophageal reflux-associated chronic cough in the Japanese population

Research

Obstructive sleep apnoea: a cause of chronic cough

Research

Cough reflex and oral chemesthesis induced by capsaicin and capsiate in healthy never-smokers

Review

Central and peripheral mechanisms of narcotic antitussives: codeine-sensitive and -resistant coughs

Research

Inhibition of citric acid- and capsaicin-induced cough by novel TRPV-1 antagonist, V112220, in guinea-pig
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits